537253 SUNLOC

Sunil Healthcare Share Price

 

Stock Result Declared

 

Start SIP in SUNLOC

Start SIP

Performance

  • Low
  • ₹66
  • High
  • ₹70
  • 52 Week Low
  • ₹61
  • 52 Week High
  • ₹89
  • Open Price₹70
  • Previous Close₹70
  • Volume2,641
  • 50 DMA₹69.90
  • 100 DMA₹71.95
  • 200 DMA₹74.06

Investment Returns

  • Over 1 Month -7.83%
  • Over 3 Month -10.39%
  • Over 6 Month -12.95%
  • Over 1 Year -14.65%

Smart Investing Starts Here Start SIP with Sunil Healthcare for Steady Growth!

Invest Now

Sunil Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 25
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 71
  • P/B Ratio
  • 1.1
  • Average True Range
  • 4.57
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.86
  • RSI
  • 51.48
  • MFI
  • 39.19

Sunil Healthcare Financials

Sunil Healthcare Technicals

EMA & SMA

Current Price
₹69.61
+ 0.06 (0.09%)
pointer
  • Bearish Moving Average 8
  • Bullish Moving Average 8
  • 20 Day
  • ₹68.49
  • 50 Day
  • ₹69.90
  • 100 Day
  • ₹71.95
  • 200 Day
  • ₹74.06

Resistance and Support

68.54 Pivot Speed
  • R3 75.07
  • R2 72.54
  • R1 71.07
  • S1 67.07
  • S2 64.54
  • S3 63.07

Sunil Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-06 Quarterly Results
2025-11-04 Quarterly Results
2025-07-30 Quarterly Results
2025-05-29 Audited Results
2025-02-13 Quarterly Results

Sunil Healthcare F&O

Sunil Healthcare Shareholding Pattern

73.53%
0.1%
17.85%
8.52%

Sunil Healthcare FAQs

Sunil Healthcare share price is ₹69 As on 07 February, 2026 | 13:06

The Market Cap of Sunil Healthcare is ₹71.4 Cr As on 07 February, 2026 | 13:06

The P/E ratio of Sunil Healthcare is 25 As on 07 February, 2026 | 13:06

The PB ratio of Sunil Healthcare is 1.1 As on 07 February, 2026 | 13:06

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23